Devlin Macgregor Pharmaceuticals Announces New 2021 Product Line
Devlin Macgregor announced general availability of three new products on Monday March 8th 2021
Devlin Macgregor announced general availability of three new products on Monday March 8th 2021
* Provasic: The newest generation of blood lipid inhibiting therapeutics, featuring patented Advanced Molecular Delivery System (AMDS), offering near 100% efficacy with absolutely no side effects.
*Narcogesic: Unique, rectally administered two-part epoxy based, pain management system featuring tamper-proof design, that allows for patient self dosing and administration
* Solarestti: The only topical titration proven to block all currently licensed, single and dual-dose mRNA based SARS-Cov-2 (COVID-19) vaccines. For use in adults and children 3 and older only.
https://devlinmacgregor.com
* Provasic: The newest generation of blood lipid inhibiting therapeutics, featuring patented Advanced Molecular Delivery System (AMDS), offering near 100% efficacy with absolutely no side effects.
*Narcogesic: Unique, rectally administered two-part epoxy based, pain management system featuring tamper-proof design, that allows for patient self dosing and administration
* Solarestti: The only topical titration proven to block all currently licensed, single and dual-dose mRNA based SARS-Cov-2 (COVID-19) vaccines. For use in adults and children 3 and older only.
https://devlinmacgregor.com
- Contact Email
- [email protected]
- Issued By
- Charles Nichols
- Phone
- 555-437-6600
- Business Address
- 1000 Wunarmman-Kimble Business Park, Suite 5150
- Country
- United States
- Categories
- Health
- Last Updated
- March 9, 2021